Nuclear transcriptional (Run on) assay
This assay was performed according to the method of Groudine et al. (20) as described previously (17, 18 Interfering effect of 1a25(OH)2D3 analogs on RA-mediated inhibition of c-fos gene expression in TNF-a-treated MC3T3-E1 cells Several recent studies (24, (26) (27) (28) (29) (30) have suggested the presence of vitamin D3 receptor (VDR)-dependent (genomic) and independent (non-genomic) pathways in the biological action of 1a25(OH)2D3. In this regard, several of them (24, (27) (28) (29) (30) (31) (32) showed that OCT, an analog derivative of 1a25(OH)2D3, had a high affinity for the VDR and that its biological action was a genomic one. In contrast, 24,25(OH)2D3 is a ligand that has very low affinity for the VDR (27, 31, 32) . Therefore, using these analogs we examined whether the 1a25(OH)2D3 interference of the RA-mediated inhibition of c-fos was VDR dependent or independent. As shown in Fig. 3 A and 3B, OCT also blocked the RA-induced inhibition of c-fos gene expression in the TNF-a-treated cells. In contrast, this was not the case for 24,250. These results suggest this hormone interference to be VDR dependent.
Involvement
of endogenous VDR in 1 a25 (OH)2D3 interference toward RA-mediated inhibition of TNF-a-induced c-fos gene expression in MC3T3-E1 cells
As described above, our data suggested involvement of an endogenous VDR in the 1a25(OH)2D3 interfering effect on RA-mediated inhibition of TNF-a-induced expression of the c-fos gene in MC3T3-E1 cells. In addition, we used mouse VDR antisense oligonucleotide to investigate the functional role of VDR in this interference. Our previous study (9) showed that in the RA-induced inhibition of the c-fos gene expression there was a marked decrease in the binding of AP-1 to TRE in TNF-oc-treated 
